Join us for an Educational Event on cIMPACT-NOW: advancing the molecular classification of ependymal tumors
National Brain Tumor Society and the CERN Foundation are hosting a virtual educational event on the new ependymoma molecular classification updates released in the
cIMPACT now update 7 publication on Thursday, September 10, 2020 at 12pm. Dr. David Ellison, Chair of Pathology at St. Jude Children’s Research Hospital, and Dr. Mark Gilbert, Chief of the Neuro Oncology Branch at the National Institutes of Health, will be interviewed by Kim Wallgren to help educate patients and care partners on how molecular classification is done, why it is important to the community, and explaining the recent updates involving ependymoma. If you would like to pre-register for the virtual event and receive emails regarding the event, email us at
administrator@cern-foundation.org.